A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LX / lipoxin

[Related PubMed/MEDLINE]
Total Number of Papers: 68
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LX  (>> Co-occurring Abbreviation)
Long Form:   lipoxin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 The role of lipoxin in regulating tumor immune microenvironments. ---
2018 Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation. DHA, EPA, LM, LPS, PUFA, Rv, SPMs
2018 Lipoxin A4 and its analog suppress hepatocarcinoma cell epithelial-mesenchymal transition, migration and metastasis via regulating integrin-linked kinase axis. ACM, EMT, ILK, PMA
2017 Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles. EMVs, miR
2017 microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. CF, miR
2017 Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages. HDL, HDLHealthy, LO, LT, Rv
2016 Epigenetic regulation of the formyl peptide receptor 2 gene. ---
2016 Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology. hPDLSCs, PDLLA, PEO
2015 Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. ATL, LO
10  2014 Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis. ASL, CF
11  2014 Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. LC-MS-MS, LM, MaR, PCA, plasma and serum, Rv, SPM
12  2014 LipoxinA4 attenuates myocardial ischemia reperfusion injury via a mechanism related to downregulation of GRP-78 and caspase-12 in rats. cTnI, IL, MDA, MIRI, MPO, SOD, TNF
13  2014 Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. ---
14  2013 Diversity of lipid mediators in human adipose tissue depots. 5-HETE, BMI, LT, PG, PVD, Rv, s.c, SPM
15  2013 Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin. Anx, IL, MIP, NGAL
16  2013 [Effects of lipoxinA4 on endoplasmic reticulum stress during myocardial ischemia reperfusion injury in rats]. cTnI, ERS, MDA, MIRI, MPO, NS, SOD
17  2012 Levocetirizine inhibits migration of immune cells to lymph nodes and induces treg cells in a murine type I allergic conjunctivitis model. AC, APC, IFN, Ig, IL, TGF, TNF, Treg
18  2012 Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. GPCRs, MaR, Rv, SPMs
19  2012 Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity. Sp1
20  2011 Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mtb
21  2011 Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. ACM, LPS
22  2010 Lipoxins: regulators of resolution. AA, LT
23  2009 Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. CNV, HA, Rv
24  2009 Determination of thromboxanes, leukotrienes and lipoxins using high-temperature capillary liquid chromatography-tandem mass spectrometry and on-line sample preparation. CLC, hMSCs, LT, SCX, TX
25  2009 Lipoxins as an immune-escape mechanism. ---
26  2009 Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia-reperfusion-induced gastric mucosal damage in rats. ---
27  2007 Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. 5-LO, LT
28  2007 Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. AERD, ATA
29  2006 RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. LAP, RvE1
30  2005 Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. AA, CysLTs
31  2005 Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. ATL
32  2005 Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. ATL, PIPP, PSDP
33  2005 Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis. LT, LXA4, PG, PMSG
34  2003 A novel rat lipoxin A4 receptor that is conserved in structure and function. ATL, GPCR
35  2003 Imbalance between lipoxin A4 and leukotriene B4 in chronic mastitis-affected cows. LT
36  2002 Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. COX-2
37  2002 Inhibition of allergen-induced eosinophil migration by lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4. ---
38  2002 Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. ATL, GPCR
39  2002 Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. IFN, IL, LO
40  2000 Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. ATL, PMN
41  2000 Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. 15-epi-LX, AIA, ATA, LT
42  2000 Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. ATL, LXA4
43  2000 Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. LJP, PG
44  2000 Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. PMN
45  1999 Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. 5-LO, ATL, LT, PMN
46  1999 Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. ATLs, LXA4, TNF
47  1999 Trout thrombocytes contain 12- but not 5-lipoxygenase activity. 12-HEPE, 12-HETE, LO, LT, MACS
48  1998 Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. 5-LO, LT, PMN
49  1998 Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. COX, IL
50  1998 Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. LTB4
51  1997 Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. LTD4, LXA4, LXA4R
52  1997 Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Con A-F, COX-II, NSN, PMN
53  1996 Electrospray-collision-induced dissociation mass spectrometry of mono-, di- and tri-hydroxylated lipoxygenase products, including leukotrienes of the B-series and lipoxins. CID, HETE, LT
54  1995 Immunoregulatory activities of eicosanoids in the rainbow trout (Oncorhynchus mykiss). LT, PFC, PG
55  1995 Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction. GEN, GM-CSF, IL-8, LO, LT, PAF, PMN, TNF
56  1995 Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. EC, LTs, vWF
57  1995 Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation. LT, PMN
58  1994 Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. LT, MPO, PG, PS, SWS
59  1994 Eicosanoid generation and effects on the aggregation of thrombocytes from the rainbow trout, Oncorhynchus mykiss. 12-HETE, LT, PG, TX
60  1993 Effect of lipoxins and other eicosanoids on phagocytosis and intracellular calcium mobilisation in rainbow trout (Oncorhynchus mykiss) leukocytes. 12-HETE, LT, PG
61  1992 15-Lipoxygenase products as leukotriene antagonists: therapeutic potential in glomerulonephritis. 5-LO, LT, PMN
62  1992 Renal hemodynamic actions of lipoxins in rats: a comparative physiological study. 5-LO, GFR, RPF
63  1991 Formation and proliferative effects of lipoxins in human bone marrow. GM-CSF
64  1991 Lipoxin formation in fish leucocytes. ---
65  1991 Regulation of lipoxins (LX) and leukotriene B4 (LTB4) production in rat mesangial cells (MC). LO, LTB4, MC
66  1991 Synthesis of lipoxins and other lipoxygenase products by macrophages from the rainbow trout, Oncorhynchus mykiss. ---
67  1990 Elevated formation of lipoxins in viral antibody-positive rat alveolar macrophages. 15-HETE, AM, LXA4, LXB4, RP-HPLC
68  1987 Nomenclature of lipoxins and related compounds derived from arachidonic acid and eicosapentaenoic acid. ---